QBFM
PFE icon

QS Batterymarch Financial Management’s Pfizer PFE Stock Holding History

QS Batterymarch Financial Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$23M Sell
818,509
-61,813
-7% -$1.73M 0.61% 25
2014
Q2 		$24.8M Sell
880,322
-236,580
-21% -$6.74M 0.63% 20
2014
Q1 		$34M Buy
1,116,902
+104,952
+10% +$3.13M 0.7% 14
2013
Q4 		$29.4M Sell
1,011,950
-95,022
-9% -$2.77M 0.62% 16
2013
Q3 		$30.2M Sell
1,106,972
-1,385
-0.1% -$37.7K 0.66% 14
2013
Q2 		$29.5M Buy
+1,108,357
New +$30.6M 0.56% 24

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

QS Batterymarch Financial Management's PFE Position: Q3 2014 in Review

QS Batterymarch Financial Management reduced its Pfizer (PFE) stake by 7% in Q3 2014, selling an estimated $1.73M and leaving 818,509 shares worth $23M. The position accounts for 0.61% of the portfolio, ranked #25.

QS Batterymarch Financial Management first reported a position in PFE in Q2 2013 and has held it in 6 quarters since. The position peaked at $34M in Q1 2014. 1,742 funds tracked by Wall St. Rank hold PFE as of Q3 2014.

  • QS Batterymarch Financial Management held 818,509 shares of Pfizer worth $23M as of Q3 2014.
  • QS Batterymarch Financial Management sold 61,813 Pfizer shares in Q3 2014, an estimated $1.73M.
  • Pfizer made up 0.61% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #25 holding.
  • QS Batterymarch Financial Management first reported a position in Pfizer in Q2 2013 and has held it in 6 quarters since.
  • QS Batterymarch Financial Management's Pfizer position peaked at $34M in Q1 2014.
  • 1,742 funds tracked by Wall St. Rank held Pfizer as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.